Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon S Howarth

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
The Journal of Nutrition|May 25, 2012
Commentary on prebiotic utility in colitis: will inflammasomics hold the key?Gordon S Howarth
The Journal of Nutrition|September 13, 2024
Probiotaceuticals: Back to the future?Gordon S Howarth
The Journal of Nutrition|December 19, 2009
Probiotic-derived factors: probiotaceuticals?Gordon S Howarth
The Journal of Nutrition|July 4, 2003
Insulin-like growth factor-I and the gastrointestinal system: therapeutic indications and safety implicationsGordon S Howarth
Journal of Gastroenterology and Hepatology|January 6, 2009
Inflammatory bowel disease, a dysregulated host-microbiota interaction: are probiotics a new therapeutic option?Gordon S Howarth
Nutrients|January 12, 2013
Role of endogenous microbiota, probiotics and their biological products in human healthGordon S Howarth, Hanru Wang
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|July 4, 2023
Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitisSuzanne Mashtoub, Gordon S Howarth
Cancer Biology & Therapy|July 28, 2009
Complementary medicines: emerging therapies for intestinal mucositisRoger Yazbeck, Gordon S Howarth
Experimental Biology and Medicine (Maywood, N.J.)|September 20, 2013
Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in ratsSuzanne Mashtoub, Cuong D Tran, Gordon S Howarth
Cytokine & Growth Factor Reviews|March 28, 2009
Growth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward?Roger Yazbeck, Gordon S Howarth, Catherine A Abbott
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Nutrition|May 25, 2012
Commentary on prebiotic utility in colitis: will inflammasomics hold the key?Gordon S Howarth
The Journal of Nutrition|September 13, 2024
Probiotaceuticals: Back to the future?Gordon S Howarth
The Journal of Nutrition|December 19, 2009
Probiotic-derived factors: probiotaceuticals?Gordon S Howarth
The Journal of Nutrition|July 4, 2003
Insulin-like growth factor-I and the gastrointestinal system: therapeutic indications and safety implicationsGordon S Howarth
Journal of Gastroenterology and Hepatology|January 6, 2009
Inflammatory bowel disease, a dysregulated host-microbiota interaction: are probiotics a new therapeutic option?Gordon S Howarth
Nutrients|January 12, 2013
Role of endogenous microbiota, probiotics and their biological products in human healthGordon S Howarth, Hanru Wang
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|July 4, 2023
Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitisSuzanne Mashtoub, Gordon S Howarth
Cancer Biology & Therapy|July 28, 2009
Complementary medicines: emerging therapies for intestinal mucositisRoger Yazbeck, Gordon S Howarth
Experimental Biology and Medicine (Maywood, N.J.)|September 20, 2013
Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in ratsSuzanne Mashtoub, Cuong D Tran, Gordon S Howarth
Cytokine & Growth Factor Reviews|March 28, 2009
Growth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward?Roger Yazbeck, Gordon S Howarth, Catherine A Abbott
Pageof 12